dr. yu on trials of moderate hypofractionation in prostate cancer
Published 7 years ago • 160 plays • Length 1:28Download video MP4
Download video MP3
Similar videos
-
1:00
dr. yu on moderate hypofractionation in prostate cancer
-
1:54
dr. yu on the significance of the protect study in prostate cancer
-
1:03
dr. yu on the drawbacks of radiation therapy in prostate cancer
-
1:28
dr. yu on emerging standards in radiation for prostate cancer
-
1:06
dr. yu on comorbidities and therapy choice in prostate cancer
-
1:10
dr. yu on the future of castration-sensitive prostate cancer
-
1:26
bridget f. koontz, md, on moderate hypofractionation & ultra-hypofractionation in prostate cancer
-
2:28
dr. yu on treatment intensification in metastatic castration-sensitive prostate cancer
-
1:42
dr. yu compares treatment options for prostate cancer
-
1:57
dr. sandler discusses hypofractionation in prostate cancer
-
0:59
dr. yu on future directions in prostate cancer
-
1:14
rationale of phase iii pcs5 trial of hypofractionated radiotherapy for prostate cancer
-
1:26
dr. john yarnold on hypofractionated radioatherapy in the start trials
-
1:17
dr. yu discusses observation versus treatment in men with prostate cancer
-
2:33
dr. yu on novel pet imaging in prostate cancer
-
1:31
dr. yuh on outcomes between rt and surgery in prostate cancer
-
1:24
the potential of moderately hypofractionated radiotherapy: analysis & future directions
-
1:30:34
session 8: prostate moderate hypofractionation
-
1:44
results of the phase iii pcs5 trial of hypofractionated radiotherapy for prostate cancer